(Q54255258)

26 May 2018

title

Somatostatin Analogue Phase I Trials in Neuroendocrine Neoplasms (English)

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

18 August 2024

main subject

phase I clinical trial

0 references

neurosecretory system

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

author name string

L. Anthony

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

D. Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

K. Hande

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

M. Shaff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

S. Winn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

M. Krozely

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

J. Oates

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686764

18 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7686764

18 August 2024

publication date

1 January 1993

1 reference

26 May 2018

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/02841869309083915

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

18 August 2024

1 reference

26 May 2018

volume

32

1 reference

26 May 2018

issue

2

1 reference

26 May 2018

page(s)

217-223

1 reference

26 May 2018

NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869309083915

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869309083915

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869309083915

G protein activation of a hormone-stimulated phosphatase in human tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869309083915

Effect of the somatostatin analogue SMS 201-995 on faecal fat excretion in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869309083915

Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869309083915

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

18 August 2024

5

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

Efficacy of somatostatin in a patient with carcinoid syndrome

18 August 2024

6

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.

18 August 2024

7

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue

18 August 2024

12

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

Identification of somatostatin receptors in human small cell lung carcinoma

18 August 2024

16

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase

18 August 2024

17

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

18 August 2024

Somatostatin

19

1 reference

https://api.crossref.org/works/10.3109/02841869309083915

18 August 2024

Identifiers

1 reference

26 May 2018

1 reference

26 May 2018